Rheumatoid Arthritis Treatment Market is expected to grow at a CAGR of 5.7% to reach US$ 79.1 Bn by the end of 2033

Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation in the joints and surrounding tissues. It is a leading cause of disability and can affect people of all ages. The severity of RA varies from person to person, and treatment typically involves a combination of medications, lifestyle changes, and physical therapy.

 Request For Free Sample Report of "Rheumatoid Arthritis Treatment Market"@ https://www.persistencemarketresearch.com/samples/22555

The Rheumatoid Arthritis Treatment market is expected to grow in the coming years due to the increasing prevalence of RA and the availability of new treatment options. The growing awareness about RA and the increasing demand for effective treatment options are also driving the market growth.

The global revenue from the rheumatoid arthritis treatment market stands at US$ 42.9 Bn in 2022, with the global market expected to grow at a CAGR of 5.7% to reach a valuation of approximately US$ 79.1 Bn by the end of 2033.

As assessed by Persistence Market Research, disease modifying anti-rheumatic drug (DMARD) therapy holds a market share of around 88.3% in 2022. Overall, rheumatoid arthritis treatment market sales account for approximately 43.1% revenue share in the global anti-inflammatory therapeutics market, which was valued at around US$ 99.6 Bn in 2022.

 Companies

Sanofi S.A.
Pfizer Inc.
Johnson & Johnson
AbbVie Inc.
Eli Lilly & Company
Amgen Inc.
Bristol-Myers Squibb Company
Hoffman-La Roche AG
Cipla, Inc.
Sun Pharmaceutical Industries Ltd.
Sobi Inc.
Novartis AG ( Sandoz)
UCB S.A.

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/22555

There are several treatment options available for RA, including non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologics. NSAIDs are commonly used to reduce pain and inflammation, while DMARDs are used to slow the progression of RA and prevent joint damage. Biologics, which are proteins produced in living cells, are a newer class of medications that target specific proteins involved in the immune system's response to RA.

Overall, the Rheumatoid Arthritis Treatment market is expected to see significant growth in the coming years due to the increasing prevalence of RA and the availability of new treatment options.

Competition Landscape

The main participants in the global market for rheumatoid arthritis treatment generally employ co-commercialization and distribution partnerships as marketing and distribution strategies.

Throughout the anticipated period, the introduction of novel JAK inhibitors for rheumatoid arthritis will stimulate market growth.

Some key instances of development within the market include:

Etanercept, a drug manufactured locally by Cipla that is prescribed to treat rheumatic disorders, was released in March 2018. The drug known by the brand name Etacept will be manufactured by Shanghai CP Guojian Pharmaceutical Co. in China and marketed by Cipla in India according to the cooperation agreement.

Avsola, a biosimilar version of the popular rheumatoid arthritis medicine Remicade manufactured by Johnson & Johnson, received approval from the U.S. Food and Drug Administration in December 2019.

 Request Customization @ https://www.persistencemarketresearch.com/request-customization/22555

Key Segments Covered in Global Rheumatoid Arthritis Treatment Market Research

Therapy:

Symptomatic Treatment

Intermediate Corticosteroid Therapies

Stem Cell Therapy

Disease Modifying Anti-rheumatic Drug (DMARD)

Conventional DMARDs

Biologic DMARDs

Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Drug Stores

For More Premium Insights, Check out the Link:

Autogenous Vaccines Market - https://www.prnewswire.com/news-releases/autogenous-vaccines-market-is-predicted-to-witness-an-impressive-cagr-of-5-5-over-the-forecast-period-2021-2031--persistence-market-research-301264988.html

Hematology Analyzers Market - https://www.prnewswire.com/news-releases/hematology-analyzers-market-will-exhibit-a-5-cagr-during-the-forecast-period-2020-to-2030---persistence-market-research-301187222.html

Bioabsorbable Implants Market - https://www.prnewswire.com/news-releases/bioabsorbable-implants-market-is-expected-to-grow-at-a-healthy-cagr-of-3-4-by-2018-to-2028---persistence-market-research-300850551.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research's Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

This release was published on openPR.